Literature DB >> 28291893

Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women.

M Sean Esplin1, Michal A Elovitz2, Jay D Iams3, Corette B Parker4, Ronald J Wapner5, William A Grobman6, Hyagriv N Simhan7, Deborah A Wing8, David M Haas9, Robert M Silver1, Matthew K Hoffman10, Alan M Peaceman6, Steve N Caritis7, Samuel Parry2, Pathik Wadhwa8, Tatiana Foroud9, Brian M Mercer11, Shannon M Hunter4, George R Saade12, Uma M Reddy13.   

Abstract

Importance: Spontaneous preterm birth is a leading cause of infant mortality. Prediction, largely based on prior pregnancy outcomes, is not possible in women pregnant for the first time. Objective: To assess the accuracy of universal screening to predict spontaneous preterm birth in nulliparous women using serial measurements of vaginal fetal fibronectin levels and cervical length. Design, Settings, and Participants: A prospective observational cohort study of nulliparous women with singleton pregnancies, from 8 clinical sites across the United States between October 2010 and May 2014. Women and clinicians were blinded to results unless cervical shortening less than 15 mm was identified. Exposures: Transvaginal cervical length and quantitative vaginal fetal fibronectin levels were reviewed at 2 study visits 4 or more weeks apart. Main Outcomes and Measures: Spontaneous preterm birth at less than 37 weeks was the primary outcome. Cervical length and quantitative fetal fibronectin were considered independently and together at each visit. Measurement distributions were compared for spontaneous preterm birth vs all other births. Spontaneous preterm birth before 32 weeks was a secondary outcome.
Results: The study included 9410 women (median age, 27.0 [interquartile range, 9.0] years; 60.7% non-Hispanic white, 13.8% non-Hispanic black, 16.5% Hispanic, 4.0% Asian, and 5.1% other), of whom 474 (5.0%) had spontaneous preterm births, 335 (3.6%) had medically indicated preterm births, and 8601 (91.4%) had term births. Among women with spontaneous preterm birth, cervical length of 25 mm or less occurred in 35 of 439 (8.0%) at 16 to 22 weeks' gestation and in 94 of 403 (23.3%) at 22 to 30 weeks' gestation. Fetal fibronectin levels of 50 ng/mL or greater at 16 to 22 weeks identified 30 of 410 women (7.3%) with spontaneous preterm birth and 31 of 384 (8.1%) at 22 to 30 weeks. The area under the receiver operating characteristic curve for screening between 22 and 30 weeks for fetal fibronectin level alone was 0.59 (95% CI, 0.56-0.62), for transvaginal cervical length alone was 0.67 (95% CI, 0.64-0.70), and for the combination as continuous variables was 0.67 (95% CI, 0.64-0.70). Conclusions and Relevance: Among nulliparous women with singleton pregnancies, quantitative vaginal fetal fibronectin and serial transvaginal ultrasound cervical length had low predictive accuracy for spontaneous preterm birth. These findings do not support routine use of these tests in such women.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28291893      PMCID: PMC5828036          DOI: 10.1001/jama.2017.1373

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

1.  Progesterone and the risk of preterm birth among women with a short cervix.

Authors:  Eduardo B Fonseca; Ebru Celik; Mauro Parra; Mandeep Singh; Kypros H Nicolaides
Journal:  N Engl J Med       Date:  2007-08-02       Impact factor: 91.245

Review 2.  Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.

Authors:  S N Deshpande; A D I van Asselt; F Tomini; N Armstrong; A Allen; C Noake; K Khan; J L Severens; J Kleijnen; M E Westwood
Journal:  Health Technol Assess       Date:  2013-09       Impact factor: 4.014

3.  Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk.

Authors:  Danielle S Abbott; Natasha L Hezelgrave; Paul T Seed; Jane E Norman; Anna L David; Phillip R Bennett; Joanna C Girling; Manju Chandirimani; Sarah J Stock; Jenny Carter; Ruth Cate; James Kurtzman; Rachel M Tribe; Andrew H Shennan
Journal:  Obstet Gynecol       Date:  2015-05       Impact factor: 7.661

4.  A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b).

Authors:  David M Haas; Corette B Parker; Deborah A Wing; Samuel Parry; William A Grobman; Brian M Mercer; Hyagriv N Simhan; Matthew K Hoffman; Robert M Silver; Pathik Wadhwa; Jay D Iams; Matthew A Koch; Steve N Caritis; Ronald J Wapner; M Sean Esplin; Michal A Elovitz; Tatiana Foroud; Alan M Peaceman; George R Saade; Marian Willinger; Uma M Reddy
Journal:  Am J Obstet Gynecol       Date:  2015-01-31       Impact factor: 8.661

5.  The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network.

Authors:  R L Goldenberg; B M Mercer; P J Meis; R L Copper; A Das; D McNellis
Journal:  Obstet Gynecol       Date:  1996-05       Impact factor: 7.661

Review 6.  Pros and cons of maternal cervical length screening to identify women at risk of spontaneous preterm delivery.

Authors:  Samuel Parry; Michal A Elovitz
Journal:  Clin Obstet Gynecol       Date:  2014-09       Impact factor: 2.190

7.  A single cervical fetal fibronectin screening test in a population at low risk for preterm delivery: an improvement on clinical indicators?

Authors:  G Faron; M Boulvain; J P Lescrainier; A Vokaer
Journal:  Br J Obstet Gynaecol       Date:  1997-06

8.  Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population.

Authors:  J B Greenhagen; J Van Wagoner; D Dudley; C Hunter; M Mitchell; V Logsdon; D Casal; M Varner
Journal:  Am J Obstet Gynecol       Date:  1996-10       Impact factor: 8.661

Review 9.  Fetal fibronectin as a biomarker of preterm labor: a review of the literature and advances in its clinical use.

Authors:  Claire Foster; Andrew H Shennan
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

10.  Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery.

Authors:  James Kurtzman; Manju Chandiramani; Annette Briley; Lucilla Poston; Anita Das; Andrew Shennan
Journal:  Am J Obstet Gynecol       Date:  2009-03       Impact factor: 8.661

View more
  38 in total

1.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

2.  Cervical Evaluation: From Ancient Medicine to Precision Medicine.

Authors:  Helen Feltovich
Journal:  Obstet Gynecol       Date:  2017-07       Impact factor: 7.661

3.  A high concentration of fetal fibronectin in cervical secretions increases the risk of intra-amniotic infection and inflammation in patients with preterm labor and intact membranes.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; Jihyun Kang; Joon-Seok Hong; Bo Hyun Yoon
Journal:  J Perinat Med       Date:  2019-04-24       Impact factor: 1.901

4.  Labour and delivery: a clinician's perspective on a biomechanics problem.

Authors:  Helen Feltovich
Journal:  Interface Focus       Date:  2019-08-16       Impact factor: 3.906

Review 5.  Screening for spontaneous preterm birth and resultant therapies to reduce neonatal morbidity and mortality: A review.

Authors:  Angelica V Glover; Tracy A Manuck
Journal:  Semin Fetal Neonatal Med       Date:  2017-12-09       Impact factor: 3.926

6.  Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study.

Authors:  Lisa D Levine; Katheryne L Downes; Julie A Romero; Hope Pappas; Michal A Elovitz
Journal:  J Matern Fetal Neonatal Med       Date:  2018-05-15

7.  Midtrimester microbial DNA variations in maternal serum of women who experience spontaneous preterm birth.

Authors:  Akila Subramaniam; William J Van Der Pol; Travis Ptacek; Elena Lobashevsky; Cherry Neely; Joseph R Biggio; Elliot J Lefkowitz; Casey D Morrow; Rodney K Edwards
Journal:  J Matern Fetal Neonatal Med       Date:  2018-07-22

8.  Prospective Evaluation of Maternal Sleep Position Through 30 Weeks of Gestation and Adverse Pregnancy Outcomes.

Authors:  Robert M Silver; Shannon Hunter; Uma M Reddy; Francesca Facco; Karen J Gibbins; William A Grobman; Brian M Mercer; David M Haas; Hyagriv N Simhan; Samuel Parry; Ronald J Wapner; Judette Louis; Judith M Chung; Grace Pien; Frank P Schubert; George R Saade; Phyllis Zee; Susan Redline; Corette B Parker
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

9.  Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eduardo Da Fonseca; John M O'Brien; Elcin Cetingoz; George W Creasy; Sonia S Hassan; Offer Erez; Percy Pacora; Kypros H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  2018-04-07       Impact factor: 8.661

10.  Association Between Features of Spontaneous Late Preterm Labor and Late Preterm Birth.

Authors:  Angelica V Glover; Ashley N Battarbee; Cynthia Gyamfi-Bannerman; Kim A Boggess; Grecio Sandoval; Sean C Blackwell; Alan T N Tita; Uma M Reddy; Lucky Jain; George R Saade; Dwight J Rouse; Jay D Iams; Erin A S Clark; Edward K Chien; Alan M Peaceman; Ronald S Gibbs; Geeta K Swamy; Mary E Norton; Brian M Casey; Steve N Caritis; Jorge E Tolosa; Yoram Sorokin; Tracy A Manuck
Journal:  Am J Perinatol       Date:  2019-09-17       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.